Dimensional Fund Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Dimensional Fund Advisors's CDLX Position: Q1 2026 in Review
Dimensional Fund Advisors sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 12,723 shares — an estimated $146K sold.
Dimensional Fund Advisors first reported a position in CDLX in Q1 2020 and held it in 16 quarters. The position peaked at $11.3M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Dimensional Fund Advisors reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
- Dimensional Fund Advisors sold 12,723 Cardlytics shares in Q1 2026, an estimated $146K.
- Dimensional Fund Advisors first reported a position in Cardlytics in Q1 2020 and held it in 16 quarters.
- Dimensional Fund Advisors's Cardlytics position peaked at $11.3M in Q1 2024.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.